glp-1 impact on food and beverage sales 2025 report What retailers should know about consumers taking GLP-1s for weight loss GLP-1: Transforming weight loss and

While they produce modest LDL cholesterol reductions of 2-10%, statins remain first-line therapy for patients requiring significant lipid lowering, and GLP-1 agents work best as complementary therapy alongside statins

Byetta is a GLP-1 receptor agonist that enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying

Regular medical supervision helps ensure safe and effective use of Ozempic, allowing for timely adjustments to treatment plans when needed

The clinical efficacy of semaglutide and tirzepatide has led to these drugs being among the most commonly prescribed in the USA, with an estimated one in eight people having used a GLP1 receptor agonist medication 4